相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Differential Responsiveness of Monocyte and Macrophage Subsets to Interferon
Shuhong Han et al.
ARTHRITIS & RHEUMATOLOGY (2020)
In the mix: the potential benefits of adding GM-CSF to CpG-B in the local treatment of patients with early-stage melanoma
Bas D. Koster et al.
ONCOIMMUNOLOGY (2020)
IFN-Alpha-Mediated Differentiation of Dendritic Cells for Cancer Immunotherapy: Advances and Perspectives
Caterina Lapenta et al.
VACCINES (2020)
Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity
Mikhail Binnewies et al.
CELL (2019)
Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy
Melvyn T. Chow et al.
IMMUNITY (2019)
Transcriptome landscape of myeloid cells in human skin reveals diversity, rare populations and putative DC progenitors
Dan Xue et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2019)
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
Matthew J. Reilley et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Discovery of specialized NK cell populations infiltrating human melanoma metastases
Lucas Ferrari de Andrade et al.
JCI INSIGHT (2019)
NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
Jan P. Boettcher et al.
CELL (2018)
Subcellular Localization of Antigen in Keratinocytes Dictates Delivery of CD4+ T-cell Help for the CTL Response upon Therapeutic DNA Vaccination into the Skin
Nikolina Babala et al.
CANCER IMMUNOLOGY RESEARCH (2018)
SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study
Antoni Ribas et al.
CANCER DISCOVERY (2018)
A Highly Active Form of XCL1/Lymphotactin Functions as an Effective Adjuvant to Recruit Cross-Presenting Dendritic Cells for Induction of Effector and Memory CD8+ T Cells
Kazuhiko Matsuo et al.
FRONTIERS IN IMMUNOLOGY (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
High-Dimensional Phenotypic Mapping of Human Dendritic Cells Reveals Interindividual Variation and Tissue Specialization
Marcela Alcantara-Hernandez et al.
IMMUNITY (2017)
Melanoma Sequentially Suppresses Different DC Subsets in the Sentinel Lymph Node, Affecting Disease Spread and Recurrence
Mari F. C. M. van den Hout et al.
CANCER IMMUNOLOGY RESEARCH (2017)
STAT2 is involved in the pathogenesis of psoriasis by promoting CXCL11 and CCL5 production by keratinocytes
Claus Johansen et al.
PLOS ONE (2017)
Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II Trials
Bas D. Koster et al.
CLINICAL CANCER RESEARCH (2017)
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger et al.
CANCER CELL (2017)
Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
Edward W. Roberts et al.
CANCER CELL (2016)
IRF8 Transcription Factor Controls Survival and Function of Terminally Differentiated Conventional and Plasmacytoid Dendritic Cells, Respectively
Dorine Sichien et al.
IMMUNITY (2016)
Differential capacity of human interleukin-4 and interferon-α monocyte-derived dendritic cells for cross-presentation of free versus cell-associated antigen
Jurjen M. Ruben et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
Miranda L. Broz et al.
CANCER CELL (2014)
Human Dermal CD14+ Cells Are a Transient Population of Monocyte-Derived Macrophages
Naomi McGovern et al.
IMMUNITY (2014)
β-Catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8+ T cells
Xinjun Liang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Dendritic cell plasticity in tumor-conditioned skin: CD14(+) cells at the cross-roads of immune activation and suppression
Rieneke van de Ven et al.
FRONTIERS IN IMMUNOLOGY (2013)
An immune-active tumor microenvironment favors clinical response to ipilimumab
Rui-Ru Ji et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Human Tissues Contain CD141hi Cross-Presenting Dendritic Cells with Functional Homology to Mouse CD103+ Nonlymphoid Dendritic Cells
Muzlifah Haniffa et al.
IMMUNITY (2012)
Characterization of four conventional dendritic cell subsets in human skin-draining lymph nodes in relation to T-cell activation
Rieneke van de Ven et al.
BLOOD (2011)
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
Mercedes B. Fuertes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Gene Signature in Melanoma Associated With Clinical Activity A Potential Clue to Unlock Cancer Immunotherapy
Thomas F. Gajewski et al.
CANCER JOURNAL (2010)
Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons
Josh Gregorio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
CpG oligodeoxynucleotides alter lymphocyte and dendritic cell trafficking in humans
W. Nicholas Haining et al.
CLINICAL CANCER RESEARCH (2008)
Local administration of PF-3512676 CpG-B instigates tumor-specific CD8+ T-cell reactivity in melanoma patients
Barbara G. Molenkamp et al.
CLINICAL CANCER RESEARCH (2008)
Intradermal CpG-B activates both plasmacytoid and myeloid dendritic cells in the sentinel lymph node of melanoma patients
Barbara G. Molenkamp et al.
CLINICAL CANCER RESEARCH (2007)
Staphylococcus aureus-derived staphopain B, a potent cysteine protease activator of plasma chemerin
Paulina Kulig et al.
JOURNAL OF IMMUNOLOGY (2007)
The tumor-draining lymph node as an immune-privileged site
David H. Munn et al.
IMMUNOLOGICAL REVIEWS (2006)
Chemokine-like receptor 1 expression by macrophages in vivo:: Regulation by TGF-β and TLR ligands
Brian A. Zabel et al.
EXPERIMENTAL HEMATOLOGY (2006)
IFN-α-conditioned dendritic cells are highly efficient in inducing cross-priming CD8+ T cells against exogenous viral antigens
Caterina Lapenta et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Matched skin and sentinel lymph node samples of melanoma patients reveal exclusive migration of mature dendritic cells
BG Molenkamp et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Plasmacytoid predendritic cells initiate psoriasis through interferon-α production
FO Nestle et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Chemokine-like receptor 1 expression and Chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood
BA Zabel et al.
JOURNAL OF IMMUNOLOGY (2005)
Local administration of granulocyte/macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma
RJCLM Vuylsteke et al.
CANCER RESEARCH (2004)
Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells
EA Moseman et al.
JOURNAL OF IMMUNOLOGY (2004)
Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas
W Vermi et al.
JOURNAL OF PATHOLOGY (2003)
Plasmacytoid dendritic cells: The key to CpG
S Rothenfusser et al.
HUMAN IMMUNOLOGY (2002)
Plasmacytoid dendritic cells:: A new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases
A Wollenberg et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Plasmacytoid dendritic cells (natural interferon-α/β-producing cells) accumulate in cutaneous lupus erythematosus lesions
L Farkas et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
分享论文
